There is mounting evidence that statin use is beneficial for COVID-19 outcomes. We
performed a systematic review and meta-analysis to evaluate the association between statin …

Statins have been widely advocated for use in COVID-19 based on large favorable
observational associations buttressed by theoretical expected benefits. However, past …

The impact of statins on COVID-19 remains unclear. This study aims to investigate whether
statin exposure assessed both in the population and in well-defined cohorts of COVID-19 …

Background There is little evidence on the relationship between statin use and the risk of
hospitalization attributable to COVID‐19. Methods and Results The French National …

The COVID pandemic has evidenced how vulnerable we are to emerging infectious
diseases and how short our current armamentarium is. Flavivirus, single stranded RNA …

Myopathy is the most common side effect of statins, but it has not been addressed effectively.
In anticipation of its wider use as a small molecule to complement the current COVID-19 …

Abstract Background Coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to multiorgan insufficiency and …

The Coronavirus Disease 2019 (COVID-19) showed worse prognosis and higher mortality in
individuals with obesity. Dyslipidemia is a major link between obesity and COVID-19 …

Background Managing the inflammatory response to SARS-Cov-2 could prevent respiratory
insufficiency. Cytokine profiles could identify cases at risk of severe disease. Methods We …

Background There currently exists limited and conflicting clinical data on the use of statins
amongst COVID-19 patients. Given the both paucity and lack of consensus among data on …